| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |